FMO5 Activators encompass a range of chemical compounds that enhance the functional activity of the flavin-containing monooxygenase 5 by increasing substrate availability, improving cofactor interaction, or stabilizing the enzyme's structure. NADPH, as a vital electron donor, and FAD, a necessary cofactor, play direct roles in facilitating FMO5's catalytic process. An abundance of NADPH ensures a consistent supply of electrons, which is crucial for the oxygenation reactions catalyzed by FMO5, whereas exogenous FAD can augment the enzyme's stability and catalytic efficiency. Substrate availability is a determining factor for FMO5's activity; thus, chemicals like Ciprofibrate, Choline, TMAO, Indole, Sulindac, Nicotine, Imipramine, and Tyramine can act as indirect activators. These substrates, when present in higher concentrations, can lead to an increased rate of FMO5-mediated metabolism. For instance, Nicotine, when metabolized, enables FMO5 to exhibit its enzymatic function more prominently. Additionally, Choline and Tyramine are natural substrates that, when provided exogenously, could saturate the enzyme, thereby potentially elevating its functional activity.
Furthermore, the indirect activation of FMO5 by these compounds is facilitated through their metabolic conversion, which is a testament to the enzyme's versatile substrate range. For example, Ciprofibrate and Sulindac, being fibrate and NSAID drugs respectively, are metabolized by FMO5, indicating that increased levels of these drugs could lead to a higher enzymatic turnover. The metabolism of Indole by FMO5 also suggests that their elevated concentrations would enhance the enzyme's activity. Moreover, the production of TMAO from trimethylamine, facilitated by FMO5, implies that higher availability of the precursor would boost the enzyme's oxygenation activity. Each of these activators, through their specific interaction with FMO5, underscores the enzyme's role in detoxifying xenobiotics, metabolizing drugs, and processing endogenous compounds, thereby extending the scope of its catalytic influence within the cell.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
β-Nicotinamide adenine dinucleotide phosphate | 53-59-8 | sc-215560 sc-215560A | 100 mg 250 mg | $182.00 $319.00 | ||
Nicotinamide adenine dinucleotide phosphate (NADPH) provides the necessary electrons for FMO5 catalytic activity. By increasing the intracellular levels of NADPH, the electron transfer to FMO5 can be enhanced, thereby potentially increasing its enzymatic activity. | ||||||
Ciprofibrate | 52214-84-3 | sc-204689 sc-204689A | 25 mg 100 mg | $58.00 $172.00 | ||
As a fibrate drug, ciprofibrate can be metabolized by FMO5. An increase in ciprofibrate levels may lead to increased FMO5 activity as it processes this substrate. | ||||||
Choline chloride | 67-48-1 | sc-207430 sc-207430A sc-207430B | 10 mg 5 g 50 g | $33.00 $37.00 $52.00 | 1 | |
Choline is a well-known substrate for FMOs. Increased levels of choline could indirectly enhance FMO5 activity by providing more substrate for its enzymatic action. | ||||||
Indole | 120-72-9 | sc-257606 sc-257606A sc-257606B sc-257606C sc-257606D | 25 g 100 g 250 g 1 kg 5 kg | $30.00 $69.00 $124.00 $270.00 $1301.00 | 3 | |
Indole can be metabolized by FMO5. Introducing indole may indirectly increase FMO5 activity by offering more substrate for its metabolic function. | ||||||
Sulindac | 38194-50-2 | sc-202823 sc-202823A sc-202823B | 1 g 5 g 10 g | $32.00 $86.00 $150.00 | 3 | |
Sulindac is a nonsteroidal anti-inflammatory drug (NSAID) that can be a substrate for FMO5. Higher availability of sulindac may lead to enhanced enzymatic action of FMO5. | ||||||
Imipramine hydrochloride | 113-52-0 | sc-207753 sc-207753B sc-207753A | 100 mg 1 g 5 g | $26.00 $45.00 $103.00 | 5 | |
Imipramine, an antidepressant, is metabolized by FMO5. Increasing the levels of imipramine could enhance the functional activity of FMO5 through its metabolism. | ||||||